Moneycontrol PRO
LAMF
LAMF

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Divis Laboratories may slip to Rs 750, Gail may test Rs 485-500: Ashwani Gujral

  • Exit Dishman Pharmaceuticals: Sharmila Joshi

  • Bull's Eye: Buy GSPL, Gayatri Projects, Natco Pharma, REC, Dredging Corp

  • Buy STC, Ceat, Dishman Pharma: Ashwani Gujral

  • Here are fundamental trading ideas from Anand Tandon

  • Buy Shriram Transport Finance Corporation, UltraTech Cement, State Bank of India: Ashwani Gujral

  • Buy Colgate, Dishman Pharma, Future Cons; sell EIL: Thakkar

  • Like BPCL, Dishman Pharma, Dish TV; V-Guard may hit Rs 275: Gaba

  • Bull's Eye: Buy Reliance Infra, Nalco, Exide, Arvind, Tata Chem

  • Bull's Eye: Buy Wockhardt, HCC, Jet, Siemens, PNB, REC, JSPL

  • Sell Bharti Infratel, TCS; buy Dishman Pharma: Ashwani Gujral

  • Bull's Eye: Buy BoI, Titan, Divis Lab, Jindal Steel, KCP, IFCI

  • Top buzzing midcap stocks to trade on February 2

  • Buy Biocon, IDBI Bank, Dishman Pharma, HPCL: Mitesh Thacker

  • Buy MOIL, NTPC, Cairn India, Dishman Pharma: Ashwani Gujral

  • Buy Colgate, Aarti Industries, Dishman Pharma: Ashwani Gujral

  • Stay Invested in Dishman Pharma, target Rs 280: Rajat Bose

  • Buy Dishman Pharma, HDFC, Eicher Motors: Ashwani Gujral

  • Sell Yes Bank, Asian Paints; buy Dishman Pharma: Ashwani Gujral

  • Sell Bharti Infratel, Bajaj Auto; buy Dishman Pharma: Wagle

  • Bull's Eye: Buy Alembic, NMDC, PC Jewellers; sell HDIL

  • Sell Ceat, Century Textiles; buy Dishman Pharma: Ashwani Gujral

  • Bull's Eye: Buy REC, Apollo Tyres, AB Nuvo; sell JSW Steel, PFC

  • Ceat may test Rs 1500, says Ashwani Gujral

  • Buy Balrampur Chini, Edelweiss Financial, Dishman Pharma: Gujral

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347